SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma.
Daley BR, Sealover NE, Finniff BA, Hughes JM, Sheffels E, Gerlach D, Hofmann MH, Kostyrko K, LaMorte JP, Linke A, Beckley Z, Frank AM, Lewis RE, Wilkerson MD, Dalgard C, Kortum RL.
Daley BR, et al. Among authors: hughes jm.
Cancer Res. 2024 Oct 22. doi: 10.1158/0008-5472.CAN-23-3256. Online ahead of print.
Cancer Res. 2024.
PMID: 39437166